A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

Clinical trial NCT06756295 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06756295
Sponsor: Fengming Kong
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer, Colorectal Cancer Melanoma Lung Cancer

Start date: 2025-03-25
Primary completion: 2028-03-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.